Pure Global
NCT05112211

Multi-model Image of Doxycycline in TAO

A Multi-model Image to Evaluate the Efficacy of Doxycycline in Thyroid Associated Ophthalmopathy
Sun Yat-sen University·ClinicalTrials.gov·drugRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Thyroid Associated Ophthalmopathy
Drug/Device/Intervention
Doxycycline Hyclate
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Sun Yat-sen University
Location
Guangzhou, China
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2020
End date
Dec 01, 2024
Enrollment
20 participants
Primary outcome

change of extraocular muscle volume and orbital fat volume by MRI

Summary

This study aims to evaluate the efficacy of doxycycline treating Thyroid Associated
 Ophthalmopathy by multi-modal image.

ICD-10 classifications
ThyroiditisDisorders of thyroid glandThyroiditis, unspecifiedOther disorders of thyroidDisorder of thyroid, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05112211
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05112211 through Pure Global AI's free database. This phase not specified trial is sponsored by Sun Yat-sen University and is currently Recruiting. The study focuses on Thyroid Associated Ophthalmopathy. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.